Sunscreen TEAs
This article was originally published in The Tan Sheet
Executive Summary
FDA requests safety and efficacy data on three sunscreens based on its determination that time and extent applications indicate the ingredients are "eligible for consideration" for inclusion in OTC monograph, according to 1July 11 Federal Register notice. Data sought on amiloxate (isoamyl p-methoxycinnamate), enzacamene (methyl benzylidene camphor) and octyl triazone by Oct. 9. TEAs for ingredients were filed by Haarmann & Reimer, Merck KgaA and BASF AG, respectively. Agency will make a final decision on ingredients' status following review of submitted information...